Sunesis To Move Novel Cell-Cycle Inhibitor Forward In Small Cell Lung Cancer
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm believes the drug, SNS-595, could offer an improved toxicity profile over GSK's Hycamtin.